Adjunctive therapies to reduce thrombotic events in patients with a history of myocardial infarction: role of vorapaxar

Acute myocardial infarction (AMI) is generally attributed to coronary atherothrombotic disease. Platelet activation is essential for thrombus formation and is thus an important target for pharmacological intervention to prevent and treat AMI. Despite contemporary treatment with dual antiplatelet the...

Descripción completa

Detalles Bibliográficos
Autores principales: Farag, Mohamed, Patel, Hiten, Gorog, Diana A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516206/
https://www.ncbi.nlm.nih.gov/pubmed/26229441
http://dx.doi.org/10.2147/DDDT.S68391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516206/
https://www.ncbi.nlm.nih.gov/pubmed/26229441
http://dx.doi.org/10.2147/DDDT.S68391

Ejemplares similares